KRAS and cancer: In different human tumor types, such as bowel subtypes (cecum, ascending and descending colon, splenic flexure, transverse colon) and sporadic CRC, with the extreme example of pancreatic and lungs cancer, the mutated KRAS acquires oncogenic properties acting as a mediator in cancer development and growth [1,2,3,4].